Use of fetal Stem-Cells in the treatment of leukemia

• Autor(a) principal: Aguiar, Jéssica Diniz
• Data de Publicação: 2018
• Outros Autores: Andrade, Simone Pôssas
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Scire Salutis
• Texto Completo: https://sustenere.inf.br/index.php/sciresalutis/article/view/SPC2236-9600.2017.002.0009
• topic: Células-tronco; Medula óssea; Leucemia; Stem cells; Bone marrow; Leukemia

In Brazil and around the world, there are patients suffering from onco-hematological diseases, such as primary myelofibrosis, multiple myeloma, leukemia and other pathologies, and daily in the various media, we hear about the freezing of umbilical cord blood , and this is due to its therapeutic potential. It is also known that the extraction of embryonic stem cells is still discussed in ethical debates, whereas obtaining stem cells withdrawn directly from the bone marrow causes a certain aversion and fear of the population; furthermore, it is confirmed that adult stem cells have their various limited sources. In this, Fetal Stem Cells fit; these can generate an identical copy to distinguish it in several types of fabrics. It is their nature that, like fetal stem cells, are classified as adult and can be removed from the umbilical cord and placenta. Taking into account these aspects, this work will contribute to the scientific community by emphasizing that fetal stem cells resent the obstacles that embryonic stem cells and adult stem cells from bone marrow and other sources have. The work will be developed based on a bibliographical, qualitative, descriptive and exploratory research, being used books, magazines and articles referring to the studied subject.